REDWOOD CITY, Calif.,
Oct. 10, 2019 /PRNewswire/ -- Nevro
Corp. (NYSE: NVRO), a global medical device company that is
providing innovative, evidence-based solutions for the treatment of
chronic pain, today announced that the Company will release its
financial results for the third quarter ended September 30, 2019 after the market closes on
November 6, 2019.
Investors interested in listening to the conference call may do
so by dialing (833) 286-5807 in the U.S. or (647) 689-4452
internationally, using Conference ID: 4787437. In addition, a live
webcast, as well as an archived recording, will be available on the
"Investors" section of the Company's website at: www.nevro.com.
About Nevro Corp.
Headquartered in Redwood City,
California, Nevro is a global medical device company focused
on providing innovative products that improve the quality of life
of patients suffering from debilitating chronic pain. Nevro has
developed and commercialized the Senza spinal cord stimulation
(SCS) system, an evidence-based, non-pharmacologic neuromodulation
platform for the treatment of chronic pain. The Senza®
System and Senza II™ System are the only SCS systems that deliver
Nevro's proprietary HF10® therapy. Senza, Senza II,
HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.
Investor Relations:
Juliet
Cunningham
Vice President, Investor Relations
650-433-3247
ir@nevro.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nevro-to-report-third-quarter-2019-financial-results-300935101.html
SOURCE Nevro Corp.